Charoen Pokphand (CP) Group has once again denied any involvement in the government's procurement of the Sinovac Covid-19 vaccine from China.
The company was responding to rumours, similar to those spread earlier which had prompted a previous statement on May 25 dismissing the claims.
Its latest remarks followed the cabinet's decision on Tuesday to procure 10.9 million more doses of Sinovac at a cost of 6.1 billion baht.
"Charoen Pokphand Group once again insists the Sinovac vaccine procurement is conducted in a government-to-government (G2G) format only, which has nothing to do with CP either directly or indirectly," it said.
CP backed any proposals for the government to import alternative Covid-19 vaccines to help achieve herd immunity against Covid-19, it said.
Suphachai Chearavanont, chief executive of CP, said the group would work side by side with the country to fight Covid-19.
"CP is confident in the country's ability and the power of unity in the public and private sectors and civic groups," he said.
CP had been affected by the crisis no less than the rest of society, he said.